Industry Growth Insights published a new data on “Biologics Outsourcing Market”. The research report is titled “Biologics Outsourcing Market research by Types (Antibody, Recombinant, Protein, Vaccines, Others), By Applications (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Other), By Players/Companies Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private, Horizon Discovery Group, Selexis, Lonza, Abzena, Adimab”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biologics Outsourcing Market Research Report
By Type
Antibody, Recombinant, Protein, Vaccines, Others
By Application
Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Other
By Companies
Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private, Horizon Discovery Group, Selexis, Lonza, Abzena, Adimab
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Biologics Outsourcing Market Report Segments:
The global Biologics Outsourcing market is segmented on the basis of:
Types
Antibody, Recombinant, Protein, Vaccines, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Catalent
- GenScript
- Innovent Biologics
- Syngene
- Shanghai Medicilon
- GL Biochem Corporation
- GVK Biosciences Private
- Horizon Discovery Group
- Selexis
- Lonza
- Abzena
- Adimab
Highlights of The Biologics Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody
- Recombinant
- Protein
- Vaccines
- Others
- By Application:
- Vaccine & Therapeutics Development
- Blood & Blood Related Products Testing
- Cellular and Gene Therapy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biologics Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biologics outsourcing is the process of contracting with a third-party company to provide biologic products or services. This can include manufacturing, testing, and distribution of biologic products.
Some of the major companies in the biologics outsourcing market are Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private, Horizon Discovery Group, Selexis, Lonza, Abzena, Adimab.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biologics Outsourcing Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Biologics Outsourcing Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Biologics Outsourcing Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Biologics Outsourcing Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Biologics Outsourcing Market Size & Forecast, 2018-2028 4.5.1 Biologics Outsourcing Market Size and Y-o-Y Growth 4.5.2 Biologics Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Biologics Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biologics Outsourcing Market Size Forecast by Type
5.2.1 Antibody
5.2.2 Recombinant
5.2.3 Protein
5.2.4 Vaccines
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biologics Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biologics Outsourcing Market Size Forecast by Applications
6.2.1 Vaccine & Therapeutics Development
6.2.2 Blood & Blood Related Products Testing
6.2.3 Cellular and Gene Therapy
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biologics Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biologics Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biologics Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Biologics Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biologics Outsourcing Market Size Forecast by Type
9.6.1 Antibody
9.6.2 Recombinant
9.6.3 Protein
9.6.4 Vaccines
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biologics Outsourcing Market Size Forecast by Applications
9.10.1 Vaccine & Therapeutics Development
9.10.2 Blood & Blood Related Products Testing
9.10.3 Cellular and Gene Therapy
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biologics Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Biologics Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biologics Outsourcing Market Size Forecast by Type
10.6.1 Antibody
10.6.2 Recombinant
10.6.3 Protein
10.6.4 Vaccines
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biologics Outsourcing Market Size Forecast by Applications
10.10.1 Vaccine & Therapeutics Development
10.10.2 Blood & Blood Related Products Testing
10.10.3 Cellular and Gene Therapy
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biologics Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biologics Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biologics Outsourcing Market Size Forecast by Type
11.6.1 Antibody
11.6.2 Recombinant
11.6.3 Protein
11.6.4 Vaccines
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biologics Outsourcing Market Size Forecast by Applications
11.10.1 Vaccine & Therapeutics Development
11.10.2 Blood & Blood Related Products Testing
11.10.3 Cellular and Gene Therapy
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biologics Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Biologics Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biologics Outsourcing Market Size Forecast by Type
12.6.1 Antibody
12.6.2 Recombinant
12.6.3 Protein
12.6.4 Vaccines
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biologics Outsourcing Market Size Forecast by Applications
12.10.1 Vaccine & Therapeutics Development
12.10.2 Blood & Blood Related Products Testing
12.10.3 Cellular and Gene Therapy
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biologics Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biologics Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biologics Outsourcing Market Size Forecast by Type
13.6.1 Antibody
13.6.2 Recombinant
13.6.3 Protein
13.6.4 Vaccines
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biologics Outsourcing Market Size Forecast by Applications
13.10.1 Vaccine & Therapeutics Development
13.10.2 Blood & Blood Related Products Testing
13.10.3 Cellular and Gene Therapy
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biologics Outsourcing Market: Competitive Dashboard
14.2 Global Biologics Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Catalent
14.3.3 GenScript
14.3.4 Innovent Biologics
14.3.5 Syngene
14.3.6 Shanghai Medicilon
14.3.7 GL Biochem Corporation
14.3.8 GVK Biosciences Private
14.3.9 Horizon Discovery Group
14.3.10 Selexis
14.3.11 Lonza
14.3.12 Abzena
14.3.13 Adimab